Showing 3071-3080 of 4166 results for "".
- Study Finds Glasses Boost Garment Worker Productivity in Indiahttps://modernod.com/news/study-finds-glasses-boost-garment-worker-productivity-in-india/2486874/Key Takeaways Providing simple near-vision glasses to garment workers increased productivity by 6%, while reducing errors and improving output quality
- Study Demonstrates Efficacy of AI in Enabling Home OCT Monitoringhttps://modernod.com/news/study-demonstrates-efficacy-of-ai-in-enabling-home-oct-monitoring/2482641/Notal Vision announced the publication of pivotal study results evaluating the performance of its artificial intelligence (AI) algorithm designed to estimate key biomarkers in wet age-
- Eyewear and Eyecare Products Are Not Included in Recently Announced European Import Dutieshttps://modernod.com/news/eyewear-and-eyecare-products-are-not-included-in-recently-announced-european-import-duties/2476937/Eyewear and eyecare products are not among the European goods that will be subjected to new tariffs, according to a communication on behalf of The Vision Council to its members Thursday, as
- Dynamin-Binding Protein Linked to Congenital Cataractshttps://modernod.com/news/dynamin-binding-protein-linked-to-congenital-cataracts/2479813/A new study has now found compelling evidence that links dynamin-binding protein (DNMBP) to congenital bilateral cataracts and severe vision loss. The study appears in the
- Opus Genetics Announces 1-Month Clinical Data from Pediatric Patient in Phase 1/2 Trial of OPGx-LCA5 Gene Therapy in Inherited Retinal Diseaseshttps://modernod.com/news/opus-genetics-announces-1-month-clinical-data-from-pediatric-patient-in-phase-12-trial-of-opgx-lca5-gene-therapy-in-inherited-retinal-diseases/2482731/Opus Genetics announced 1-month clinical data from the first pediatric patient treated with its investigational gene therapy, OPGx-LCA5, in an ongoing phase 1/2 open-label trial. The therapy is aimed at treating LCA5-related inherited retinal disease.
- Clearside Biomedical Announces Positive Results in Safety, Durability and Biologic Effect in OASIS Phase 1/2a Clinical Trial of Suprachoroidal CLS-AX in Wet AMD Patientshttps://modernod.com/news/clearside-biomedical-announces-positive-results-in-safety-durability-and-biologic-effect-in-oasis-phase-12a-clinical-trial-of-suprachoroidal-cls-ax-in-wet-amd-patients/2481234/Clearside Biomedical announced positive results from its OASIS phase 1/2a clinical trial of CLS-AX (axitinib injectable suspension) administered by suprachoroidal injection via Clearside’s SCS Microinjector in wet age-related macular degeneration (AMD) patients. Trial results include f
- PatientPoint Acquires Rendia to Accelerate Expansion into Ophthalmology Specialtyhttps://modernod.com/news/patientpoint-acquires-rendia-to-accelerate-expansion-into-ophthalmology-specialty/2481166/PatientPoint announced the acquisition of Rendia, a provider of point-of-care content for eye care providers sold on a subscription basis. Terms of the deal were not disclosed. With PatientPoint’s expansion into ophthalmology and optometry, PatientPoint’
- Haag-Streit Diagnostics to Host Online Education Events as Part of Perimetry Focus Monthhttps://modernod.com/news/haag-streit-diagnostics-to-host-online-education-events-as-part-of-its-perimetry-focus-month/2478932/Beginning today, Haag-Streit Diagnostics will host a variety of online education events on visual field testing as part of its Perimetry Focus Month. The webinars will offer educational content paired with Haag
- 2018 Best of Eyetubehttps://modernod.com/news/2018-best-of-eyetube/2476238/Cataract & Refractive Surgery Today (CRST) has compiled the best content of 2018 from Eyetube.net, the leading video resource for ophthalmologists. Below are descriptions of a few of the top videos. To view all of the videos and their descriptions, click
- Visionary Optics New Scleral Lens Design, Europa Tangenthttps://modernod.com/news/visionary-optics-new-scleral-lens-design-europa-tangent/2481375/Visionary Optics announced the launch of Europa Tangent, a scleral lens that combines a customizable design with a streamlined fitting process. The lens design is based on clinical experience and analysis of over 10,000 fittings driven by profilometry data and Visionary Optics’ sc